Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity Regulatory News (FSV)

Share Price Information for Fidelity (FSV)

Share Price is delayed by 15 minutes
Get Live Data
424.50    1.50 (0.35%)
Bid:
424.50
Ask:
426.00
Spread: 1.50 (0.353%)
Market Cap: £1.38b
FSV Live PriceLast checked at - London Stock Exchange

Intraday Fidelity Share Chart

Hardman&Co- Making a case study for outperformance

17 Mar 2023 14:45

RNS Number : 4127T
Fidelity Special Values PLC
17 March 2023
 

Hardman & Co Research on Fidelity Special Values Plc (FSV):

Making a case study for outperformance

 

With FSV having recently reached a decade of outperformance under fund manager Alex Wright's stewardship, we look at what has made this happen. We outline the investment process, and then provide a couple of detailed case studies to illustrate how it works in practice. The approach is essentially a contrarian one, using Fidelity's experienced team of analysts to look for unappreciated companies where there is a catalyst for change. This is underpinned by low valuations, which are used to provide downside protection, rather than being the source of outperformance that a conventional value approach might take.

 

Please click on the link below for the full report:

https://hardmanandco.com/research/corporate-research/making-a-case-study-for-outperformance/

If you are interested in meeting the company, you can register your interest by clicking on the above link.

 

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Brian Moretta+44 (0)203 693 7075

 

bm@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAJRMITMTTBBIJ
Date   Source Headline
8th Apr 20257:59 amRNSNet Asset Value(s)
7th Apr 20258:04 amRNSNet Asset Value(s)
4th Apr 20257:55 amRNSNet Asset Value(s)
3rd Apr 20252:11 pmPRNPortfolio Update
3rd Apr 20257:39 amRNSNet Asset Value(s)
2nd Apr 20257:33 amRNSNet Asset Value(s)
1st Apr 20254:13 pmPRNTotal Voting Rights
1st Apr 20258:30 amRNSNet Asset Value(s)
31st Mar 20257:53 amRNSNet Asset Value(s)
28th Mar 20257:50 amRNSNet Asset Value(s)
27th Mar 20257:31 amRNSNet Asset Value(s)
26th Mar 20255:26 pmPRNTransaction in Own Shares
26th Mar 20257:31 amRNSNet Asset Value(s)
25th Mar 20257:38 amRNSNet Asset Value(s)
25th Mar 20257:30 amPRNCompliance with Market Abuse Regulations
24th Mar 20256:13 pmPRNMonthly Factsheet
24th Mar 20257:29 amRNSNet Asset Value(s)
21st Mar 20257:46 amRNSNet Asset Value(s)
20th Mar 20257:21 amRNSNet Asset Value(s)
19th Mar 20257:27 amRNSNet Asset Value(s)
18th Mar 20258:04 amRNSNet Asset Value(s)
17th Mar 20257:36 amRNSNet Asset Value(s)
14th Mar 20257:46 amRNSNet Asset Value(s)
13th Mar 20257:31 amRNSNet Asset Value(s)
12th Mar 20257:32 amRNSNet Asset Value(s)
11th Mar 20257:43 amRNSNet Asset Value(s)
10th Mar 20257:53 amRNSNet Asset Value(s)
7th Mar 20257:33 amRNSNet Asset Value(s)
6th Mar 20257:30 amRNSNet Asset Value(s)
5th Mar 20257:56 amRNSNet Asset Value(s)
4th Mar 20257:47 amRNSNet Asset Value(s)
3rd Mar 20256:16 pmPRNTotal Voting Rights
3rd Mar 20257:38 amRNSNet Asset Value(s)
28th Feb 20255:04 pmPRNTransaction in Own Shares
28th Feb 20257:45 amRNSNet Asset Value(s)
27th Feb 20255:07 pmPRNTransaction in Own Shares
27th Feb 202510:51 amPRNMonthly Factsheet
27th Feb 20257:31 amRNSNet Asset Value(s)
26th Feb 20255:49 pmPRNTransaction in Own Shares
26th Feb 20257:31 amRNSNet Asset Value(s)
25th Feb 20257:29 amRNSNet Asset Value(s)
24th Feb 20257:43 amRNSNet Asset Value(s)
21st Feb 20257:27 amRNSNet Asset Value(s)
20th Feb 20257:27 amRNSNet Asset Value(s)
19th Feb 20257:18 amRNSNet Asset Value(s)
18th Feb 20257:17 amRNSNet Asset Value(s)
17th Feb 20257:32 amRNSNet Asset Value(s)
14th Feb 20257:28 amRNSNet Asset Value(s)
13th Feb 20257:28 amRNSNet Asset Value(s)
12th Feb 20257:35 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.